Skip to main content
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2009 Nov 27;5(1):142. doi: 10.1208/pt050119

Triamterene-β-cyclodextrin systems: Preparation, characterization and in vivo evaluation

Alka Pravin Mukne 1,, MS Nagarsenker 1,
PMCID: PMC2784853  PMID: 15198540

Abstract

The purpose of this research was to improve the solubility and therefore dissolution and bioavailability of triamterene, a poorly water soluble diuretic, by complexation with β-cyclodextrin. Triamterene has been reported to show low bioavailability after oral administration, with wide intersubject variation. This study presents the formulation of solid dispersions of triamterene with β-cyclodextrin—by cogrinding, kneading, and coevaporation, using low pH conditions—and their characterizations, evaluation of improvement in dissolution profiles, and in vivo advantage. Phase solubility studies indicated complex with possible stoichiometry of 1∶1 and a stability constant of 167.67M−1. The solid dispersions were characterized by Fourier transform infrared spectroscopy, nuclear magnetic resonance, x-ray diffraction, and differential scanning calorimetry studies. The characterization studies confirmed inclusion of the phenyl ring of triamterene within the nonpolar cavity of β-cyclodextrin in the coevaporate. Remarkable improvement in in vitro drug release profiles in 0.1 N HCl and pH 6.8 phosphate buffer was observed with all dispersions, especially the coevaporate. The coevaporate, when administered orally in rats, also exhibited improved in vivo activity, as measured by net sodium ion excretion, as compared with triamterene powder. Thus, coevaporation of the drug and β-cyclodextrin from acidified alcohol provide the optimum condition for inclusion complexation to give a binary system with remarkable improvement in in vitro drug release profile and in vivo performance.

Keywords: triamterene, β-cyclodexrin, coevaporate

Full Text

The Full Text of this article is available as a PDF (637.5 KB).

References

  • 1.Kapoor VK. Triamterene. In: Brittain H, editor. Analytical Profiles of Drug Substances and Excepients. San Diego, CA: Elsevier Inc, Science & Technology/Academic Press; 1994. pp. 571–605. [Google Scholar]
  • 2.Sir Dollery C. Therapeutic Drugs. London, UK: Churchill Livingstone; 1991. pp. T129–T132. [Google Scholar]
  • 3.Dittert LW, Higuchi T, Reese DR. Phase solubility technique in studying the formation of complex salts of triamterene. J Pharm Sci. 1964;53:1325–1328. doi: 10.1002/jps.2600531108. [DOI] [PubMed] [Google Scholar]
  • 4.Gines JM, Arias MJ, Holgado MA, Arevalo MF, Rabasco AM. Dissolution rate study of fresh and aging triamterene—urea solid dispersions. Drug Dev Ind Pharm. 1995;20:2729–2740. doi: 10.3109/03639049409042676. [DOI] [Google Scholar]
  • 5.Gines JM, Arias MJ, Rabasco AM, Sanchez-Soto PJ. Thermal analysis of the system triamterene—D-mannitol. J Therm Anal. 1994;42:143–158. doi: 10.1007/BF02546997. [DOI] [Google Scholar]
  • 6.Arias MJ, Gines JM, Moyano JR, Perez-Martinez JI, Rabasco AM. Influence of the preparation method of solid dispersions on their dissolution rate: Study of triamterene—D-mannitol system. Int J Pharm. 1995;123:25–31. doi: 10.1016/0378-5173(95)00026-F. [DOI] [Google Scholar]
  • 7.Arias MJ, Gines JM, Moyano JR, Rabasco AM. Dissolution properties and in vivo behaviour of triamterene in solid dispersions with polyethylene glycols. Pharm Acta Helv. 2004;71:229–235. doi: 10.1016/S0031-6865(96)00017-9. [DOI] [PubMed] [Google Scholar]
  • 8.Bekers O, Uijtendaal EV, Beijnen JJH, Bult A, Underburg WJM. Cyclodextrins in the Pharmaceutical field. Drug Dev Ind Pharm. 1991;17:1503–1542. doi: 10.3109/03639049109026630. [DOI] [Google Scholar]
  • 9.Gines JM, Arias MJ, Novak C, Sanchez-Soto PJ, Ruiz-Conde A, Morillo E. Thermal study of complex formation of triamterene with β-cyclodextrin by spray drying and cogrinding. J Therm Anal. 1995;45:659–666. doi: 10.1007/BF02548880. [DOI] [Google Scholar]
  • 10.Arias MJ, Gines JM, Moyano JR. Investigation of the triamterene—β-cyclodextrin system prepared by cogrinding. Int J Pharm. 1997;153:181–189. doi: 10.1016/S0378-5173(97)00101-4. [DOI] [Google Scholar]
  • 11.Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instr. 19-;4:117–212. [Google Scholar]
  • 12.Szetli J. Molecular entrapment and release properties of drugs by cyclodextrins. In: Smollen VF, Ball L, eds.Controlled Drug Biocrvailability: Bioavailability Control by Drug Delivery System Design. Vol 3. Wiley Interscience Publication. 1985;365–420.
  • 13.Weinstock J, Dunoff RY, Sutton R, et al. Pteridines. VI. Preparation of some 6-aryl-7-amino pteridines. J Med Chem. 1968;11:549–556. doi: 10.1021/jm00309a030. [DOI] [PubMed] [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES